PegIFN-α2aJNJ-3989JNJ-73763989bersacapavirpegylated interferon-α2ahepatitis BNCT04439539
…0 mg daily) for 36–52 weeks (induction) followed by 12 weeks of PegIFN-α2a (180 µg weekly) add-on. The primary endpoint was the proportion…
1articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: PegIFN-α2a ×
PegIFN-α2a
This drug is selected. Its supporting articles are shown below.